← Back to Search

Modified EAET for prediabetes for Prediabetes

N/A
Waitlist Available
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 3-month follow-up and 6-month follow-up
Awards & highlights

Study Summary

This trial will test if a new therapy can help people with prediabetes.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 3-month follow-up and 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3-month follow-up and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
C-peptide
HbA1c
Secondary outcome measures
Body mass index
Health behavior
Perceived Stress Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: Modified EAET for PrediabetesExperimental Treatment1 Intervention
Small groups of people with prediabetes will meet for 4, weekly, 2-hour sessions by telehealth, and will engage in modified EAET for prediabetes
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Modified EAET for prediabetes
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
309 Previous Clinical Trials
109,044 Total Patients Enrolled
~5 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top